Rab Diagnostics specializes in biomarker development for oncology-focused Antibody-Drug Conjugates (ADCs). Through our proprietary RabCANCER platform and deep expertise in intracellular drug trafficking, we provide high-quality, mechanism-driven insights to accelerate drug development and enable precision medicine.
We bridge the gap between preclinical discoveries and clinical implementation by developing robust research tools and diagnostic kits, translating insights into clinical solutions.
Based on world class science at Oslo University Hospital and headquartered in Oslo, Norway, collaborative partnerships and scientific rigor are in our DNA. We support biopharmaceutical companies in delivering precise, effective cancer therapies to patients worldwide.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Ullernchausséen 64, Oslo,0379,norway
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.rabdiagnostics.com/
- HQ
- Oslo
Rab Diagnostics Questions
Rab Diagnostics's website is https://www.rabdiagnostics.com/
Rab Diagnostics's LinkedIn profile is https://no.linkedin.com/company/rab-diagnostics
Rab Diagnostics has
7 employees.
View email and phone details for 7
employees at Rab Diagnostics.
Rab Diagnostics's industry is
Biotechnology Research
Rab Diagnostics's top competitors are
Hydroflow,
Sportai,
Vouch Careers 🤝,
Hydroflow Technologies,
Qubit Energy,
Pilea Insights,
Bú Composite,
Klyv Therapeutics As,
Chargitect,
Dnb.
Rab Diagnostics's categories are Biotechnology Research
Rab Diagnostics's founding year is 2023
